Hepatocellular Carcinoma: A Critical Complication in Patients Treated with Pyridoxal Phosphate
Neuropediatrics · 01.02.2026 · 57 (01) · 059-064
DOI: 10.1055/a-2773-6076 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropediatrics, erschienen am 01.02.2026. Verfasst von Marion M Brands und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Metabolic Diseases, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UM…. Hauptthemen laut MEDLINE: Pyridoxal Phosphate, Carcinoma, Hepatocellular, Liver Neoplasms, Epilepsy. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pyridoxal-5′-phosphate (PLP) is in most patients the effective treatment for pyridox(am)ine-5′-phosphate oxidase (PNPO) deficiency, a rare autosomal recessive cause of neonatal-onset developmental and epileptic encephalopathy. Although generally considered safe, long-term high-dose PLP exposure may have hepatotoxic effects, particularly in the absence of pharmaceutical-grade formulations. We report a series of four pediatric patients with vitamin B6–dependent epilepsy who received long-term PLP therapy. Two had genetically confirmed PNPO deficiency, and two were later diagnosed with ALDH7A1 deficiency. All received high-dose oral PLP, with frequent changes in formulation due to availability issues. Three of the four patients developed hepatocellular carcinoma after several years of PLP treatment; one developed fully reversible severe hepatotoxicity. The shared exposure to prolonged high-dose PLP across all affected patients, despite differing metabolic conditions, suggests a possible role for PLP toxicity independent of the underlying metabolic disorder. Known toxic mechanisms include mitochondrial dysfunction, Schiff base–mediated protein modification, and accumulation of reactive PLP degradation products. In two patients, the total PLP dose was successfully reduced by over 30% through increasing administration frequency, without loss of seizure control. These findings raise significant concerns about the long-term hepatic safety of oral PLP in patients with vitamin B6–dependent epilepsies. As intravenous PLP is unfeasable for lifelong therapy, there is an urgent need for standardized, high-quality PLP preparations and exploration of alternative delivery routes such as intranasal administration. Regular hepatic monitoring should be implemented in all patients receiving chronic PLP therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Metabolic Diseases, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
- Department of Pediatrics, Reference Center for Inborn Errors of Metabolism, Necker Hospital, APHP, Université Paris-Cité, G2m Network, MetabERN, Paris, France.
- Departments of Neurology and Pediatrics, University of Washington, Seattle, Washington, United States.
- Department of Pediatrics, Duke University, Durham, North Carolina, United States.
- INSERM UMR _S1163, Institut Imagine, Université Paris-Cité, Paris, France.
- Department of Child Neurology, Emma's Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
ORCID-Profile: Marion M Brands
Zitieren
APA
Brands, M. M., de Puyraimond, C., Gospe, S. M., Schiff, M. M., Jaeger, B., Koot, B. G., Raphael, M. F., Lubout, C. M., Soto, B., Delanne, J., Imbard, A., Zempel, J., Kraal, K. C., Scheenstra, R., & Clayton, P. T. (2026). Hepatocellular Carcinoma: A Critical Complication in Patients Treated with Pyridoxal Phosphate. Neuropediatrics, 57(01), 059-064. https://doi.org/10.1055/a-2773-6076
Vancouver
Brands MM, de Puyraimond C, Gospe SM, Schiff MM, Jaeger B, Koot BG, et al. Hepatocellular Carcinoma: A Critical Complication in Patients Treated with Pyridoxal Phosphate. Neuropediatrics. 2026;57(01):059-064. doi:10.1055/a-2773-6076
BibTeX
@article{Brands2026,
author = {Brands, Marion M and de Puyraimond, Chloé and Gospe, Sidney M and Schiff, Manuel M and Jaeger, Bregje and Koot, Bart G and Raphael, Martine F and Lubout, Charlotte M and Soto, Bertrand and Delanne, Julian and Imbard, Apolline and Zempel, John and Kraal, Kathelijne C and Scheenstra, René and Clayton, Peter T},
title = {Hepatocellular Carcinoma: A Critical Complication in Patients Treated with Pyridoxal Phosphate},
journal = {Neuropediatrics},
year = {2026},
volume = {57},
number = {01},
pages = {059--064},
doi = {10.1055/a-2773-6076}
}
EUVIMED